Aegis maintains the highest clinical success rates in the industry
 
  
Press Release 
AEGIS PAAG PETITIONS IN PROTEST AGAINST PROPOSED BUDGET CUTS IN DRUG MEDI-CAL RATES

4/11/2008 - Canoga Park, California, April 11, 2008, Steve Day, Chairman, submitted the Patient Advisory and Advocacy Group’s (“PAAG”) formal protest against the Governor’s proposal for a reduction of 2008-09 Drug Medi-Cal rates.

Mr. Day, expressed the PAAG stance that “The present rates and level of services are essential for the continued successful recovery of patients in Narcotic Treatment Programs. We believe that any reduction in the quality and level of services that patients are presently receiving may result in unnecessary relapses, incarcerations, as well as trauma to the patients, their families, and the communities in which they reside.”

Furthermore, the PAAG shared in its petition the fact that, “The proposed budget cuts will not resolve the budget deficit, but would ultimately result in additional direct and indirect costs to the State. Such contentions are supported by repeated studies, which have concluded that for every dollar spent on drug treatment, the State saves seven ($7) dollars in other direct and indirect costs, including legal, medical, welfare, etc.”

Steve Maulhardt, Vice President, added that, “We appreciate the support of our patients, and specifically the efforts of the PAAG. The partnership between Aegis and its patients has been very effective, and their testimonials to the State Senate and Assembly Budget Committees has provided the legislators with significant insight into the successful recovery of our patients. Additional, their testimony provided a better perspective on the damage that budget cuts could cause to this great success story.

The Patient Advisory & Advocacy Group (“PAAG”) is committed to represent and pursue the best interests of the opiate dependent patient and all other substance dependent patients or clients in the population served by Aegis Medical Systems, Inc. (“AMS”), Aegis Institute, Inc., (“AI”) and Nationwide Medical Group, Inc. (“NMG”).

Go Back